BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2020 9:17:13 AM | Browse: 763 | Download: 1749
 |
Received |
|
2020-04-19 14:47 |
|
Peer-Review Started |
|
2020-04-19 14:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-05-20 06:29 |
|
Revised |
|
2020-05-25 09:15 |
|
Second Decision |
|
2020-08-25 07:22 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-08-26 04:46 |
|
Articles in Press |
|
2020-08-26 04:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-09-05 01:54 |
|
Typeset the Manuscript |
|
2020-10-13 06:24 |
|
Publish the Manuscript Online |
|
2020-10-14 09:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Prevalence and impact of diabetes in patients with COVID-19 in China
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Min Du, Yu-Xin Lin, Wen-Xin Yan, Li-Yuan Tao, Min Liu and Jue Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
71934002 |
|
| Corresponding Author |
Jue Liu, PhD, Associate Professor, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijng 100191, China. liujue7@163.com |
| Key Words |
Diabetes; COVID-19; Systematic review; Meta-analysis; Prevalence; Impact |
| Core Tip |
At present, the prevalence and impact of diabetes on coronavirus disease 2019 (COVID-19) infection has not been systematically reviewed in China. This meta-analysis firstly focused on the pooled prevalence of diabetes among COVID-19 patients and its impact on clinical outcomes (ICU admission, severity and death) in China. The analysis showed that the pooled prevalence of diabetes was 10% [95% confidence interval (CI): 7%-15%] in COVID-19 patients. Besides, the risk of severe cases (risk ratio = 2.13, 95%CI: 1.76-2.56, I2 = 49%, P = 0.007) and deaths (risk ratio = 3.16, 95%CI: 2.64-3.78, I2 = 34%, P = 0.20) were both higher in COVID-19 patients with diabetes compared with patients without diabetes. It highlights the need for targeted intervention on diabetes among COVID-19 patients. |
| Publish Date |
2020-10-14 09:17 |
| Citation |
Du M, Lin Y, Yan W, Tao L, Liu M, Liu J. Prevalence and impact of diabetes in patients with COVID-19 in China. World J Diabetes 2020; 11(10): 468-480 |
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i10/468.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i10.468 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
